CereVasc, Inc. is developing the eShunt System for the treatment of patients with communicating hydrocephalus, one of the most common neurological conditions affecting both children and adults.
| Website | http://www.cerevasc.com |
| Revenue | $7.5 million |
| Employees | 37 (28 on RocketReach) |
| Founded | 2014 |
| Address | 100 1st Ave Suite 403, Boston, Massachusetts 02129, US |
| Phone | +1 614-777-1000 |
| Technologies |
JavaScript
,
HTML
,
PHP
+15 more
(view full list)
|
| Industry | Retail, Medical Equipment Manufacturing, Therapeutic Devices, Diagnostic Equipment |
| Keywords | Neurological Surgery, Neurological Technology |
| Competitors | Siemens, Johnson & Johnson, Medtronic, Abbott, Stryker, Boston Scientific, Cook Medical, Penumbra, Inc., CR Bard - Europe, Middle East and Africa (EMEA), Terumo +37 more (view full list) |
| SIC | SIC Code 38 Companies, SIC Code 384 Companies |
| NAICS | NAICS Code 339 Companies, NAICS Code 33 Companies |
Looking for a particular CereVasc employee's phone or email?
The CereVasc annual revenue was $7.5 million in 2026.
Daniel Levangie is the President and CEO of CereVasc.
28 people are employed at CereVasc.
CereVasc is based in Boston, Massachusetts.
The NAICS codes for CereVasc are [339, 33].
The SIC codes for CereVasc are [38, 384].